Clinical application of microRNAs in glomerular diseases

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• RNA interference (RNAi) is a fundamental biological process conserved across organisms, regulating gene expression through non-coding RNAs.
• MicroRNAs (miRNAs) are key players in RNAi, controlling gene transcription and post-transcriptional mRNA processing.
• Complex regulatory networks arise as single miRNAs target multiple genes and multiple miRNAs regulate single genes.

Approach:

• This review synthesizes current knowledge on the role of miRNAs in biological pathways.
• It examines the application of RNAi technologies, specifically miRNAs, for selective gene manipulation in research and therapeutic development.
• The focus is on the potential of miRNAs as biomarkers and novel therapeutic agents for glomerular diseases.

Key Points:

• miRNAs offer precise control over gene expression, impacting numerous biological pathways.
• RNAi-based strategies, particularly using miRNAs, have proven effective for manipulating gene transcription both in vitro and in vivo.
• The intricate regulatory functions of miRNAs highlight their significance in understanding gene expression complexity.

Conclusions:

• miRNAs are pivotal tools in basic biological research due to their ability to selectively modulate gene transcription.
• Their complex regulatory roles position them as promising candidates for targeted therapeutic interventions.
• This review underscores the potential of miRNAs as diagnostic biomarkers and innovative therapeutics for glomerular disease.